Cite
HARVARD Citation
Segec, A. et al. (2021). Does additional monitoring status increase the reporting of adverse drug reactions? An interrupted time series analysis of EudraVigilance data. Pharmacoepidemiology and drug safety. 30 (3), pp. 350-359. [Online].